Search
pralatrexate (Folotyn)
Indications:
- peripheral T-cell lymphoma
Monitor:
- liver function tests prior to 1st & 4th dose of each cycle [2]
Mechanism of action:
- folate analog
- inhibition of folate metabolism
General
antineoplastic agent (chemotherapeutic agent)
References
- Prescriber's Letter 17(2): 2010
New Drugs Approved by the FDA in 2009
Detail-Document#: 260213
(subscription needed) http://www.prescribersletter.com
- Prescriber's Letter 17(7): 2010
Recommended Lab Monitoring for Common Medications
Liver Function Test Scheduling
Detail-Document#: 260704
(subscription needed) http://www.prescribersletter.com